News

Treventis Partners its Preclinical Program in Alzheimer’s Disease with Takeda

July 3, 2023
April 11, 2023 – Toronto, Ontario, Canada – Treventis Corporation, a privately held biotechnology company, announced today that it has…
Read More

Tech Update: A new approach to Alzheimer’s and proof that video calls are exhausting

April 27, 2023
Small Canadian biotech start-up Treventis is playing in the big leagues. The Toronto company just secured a partnership with Takeda, Japan’s largest…
Read More

The Pharma Letter: Takeda partners with Treventis on Alzheimer’s disease research

April 13, 2023
Japan’s largest drugmaker Takeda (TYO: 4502) has linked up with little-known Canadian biotech Treventis for the further research, development, and…
Read More

UHN: Takeda licenses small molecule developed by researchers at UHN’s Krembil Brain Institute, targeting tau protein implicated in Alzheimer’s disease

April 13, 2023
(Toronto, April 11, 2023) – As announced today in a press release by biotechnology company Treventis, global pharmaceutical company Takeda…
Read More

Endpoints News: Takeda joins forces with small private biotech for preclinical Alzheimer’s research

April 13, 2023
Takeda is wading deeper into Alzheimer’s disease research with a new preclinical collaboration announced Tuesday. The company will work with…
Read More

Treventis Partners its Preclinical Program in Alzheimer’s Disease with Takeda

April 11, 2023
April 11, 2023 – Toronto, Ontario, Canada – Treventis Corporation, a privately held biotechnology company, announced today that it has…
Read More

Treventis Awarded $2.97M Grant from the U.S. Department of Defense

October 18, 2022
Funds for Development of a Drug Against Neurodegenerative Diseases October 18, 2022 BERNVILLE, Pennsylvania – Treventis Corporation, a privately held…
Read More

Treventis founder Sultan Darvesh awarded Jubilee Medal

August 5, 2022
Treventis is pleased to congratulate our founder Dr. Sultan Darvesh, neurologist and Dalhousie professor, for being one of the first…
Read More

Treventis founders give invited lectures at WATOC

June 30, 2022
Treventis founders Donald Weaver and Christopher Barden are both invited speakers at the 12th Triennial Congress of the World Association…
Read More

Dr. Donald Weaver, Oskar Fischer Prize Winner

June 8, 2022
Congratulations to our own Dr. Donald Weaver, Treventis founder and Chief Medical Officer, for being an Oskar Fischer Prize winner!…
Read More
1 2 3 5

Share this page

Facebook
Twitter
LinkedIn
Email
#pf-body .pf-caption img.blockImage { margin: 0!important; float: none; } #pf-body a.elementor-icon, #pf-body a.skip-link{display:none!important;} /*#pf-content img.pf-large-image {max-width:100%!important}*/ #pf-content img.mediumImage, #pf-content figure.mediumImage { margin-left: auto!important; margin-right: auto!important; clear: both!important; float: none!important; display: block!important; }